Back to CVE records
Critical 9.8Published Mar 31, 2026

CVE-2026-30311Ridvay Code's command auto-approval module contains a critical OS command injection vulnerability that renders its whitelist security mechanism completely ineffective.

Updated under an hour ago ()

Does this affect you?

It affects ridvay auto-approval_module. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Ridvay Code's command auto-approval module contains a critical OS command injection vulnerability that renders its whitelist security mechanism completely ineffective. The system relies on fragile regular expressions to parse command structures; while it attempts to intercept dangerous operations, it fails to account for standard Shell command substitution Ridvay Code (specifically$(...)and backticks ...). An attacker can construct a command such as git log --grep="$(malicious_command)", forcing Syntx to misidentify it as a safe git operation and automatically approve it. The underlying Shell prioritizes the execution of the malicious code injected within the arguments, resulting in Remote Code Execution without any user interaction.

CVSS
9.8 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-78
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jul 25, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
ridvay auto-approval_module
ridvay:auto-approval_module
through 0.1.1
NVD

References

  • third-party-advisory
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.